SB 202190, CAS [[152121-30-7]]

Produktübersicht

• Artikelname: SB 202190, CAS [[152121-30-7]]
• Artikelnummer: TGM-T2301
• Hersteller Artikelnummer: T2301
• Alternativnummer: TGM-T2301-1MLX10MM(INDMSO),TGM-T2301-25MG,TGM-T2301-50MG,TGM-T2301-100MG,TGM-T2301-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: FHPI , SB202190

Produktbeschreibung

SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38alpha and p38beta2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also induces the differentiation of human embryonic stem cells into cardiomyocytes.

Produkteigenschaften

• Molekulargewicht: 331.34
• Reinheit: 99.84%
• CAS Nummer: [152121-30-7]
• Formel: C20H14FN3O
• Target-Kategorie: p38 MAPK|||Autophagy|||Apoptosis

Bilder

T2301